Verrica Pharmaceuticals, Inc. (VRCA)
4.21
+0.03
(+0.72%)
USD |
NASDAQ |
Oct 09, 12:42
Verrica Pharmaceuticals Price : 4.21 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 4.14 | 4.29 | 4.05 | 4.18 | 37188.00 |
| Oct 07, 2026 | 4.15 | 4.330 | 4.06 | 4.14 | 47653.00 |
| Oct 06, 2026 | 4.36 | 4.41 | 4.17 | 4.21 | 41313.00 |
| Oct 05, 2026 | 4.34 | 4.539 | 4.25 | 4.31 | 35043.00 |
| Oct 02, 2026 | 4.56 | 4.843 | 4.37 | 4.38 | 44714.00 |
| Oct 01, 2026 | 4.85 | 4.85 | 4.515 | 4.515 | 55307.00 |
| Sep 30, 2026 | 4.51 | 5.04 | 4.51 | 4.795 | 50992.00 |
| Sep 29, 2026 | 4.67 | 4.67 | 4.453 | 4.46 | 3703.00 |
| Sep 28, 2026 | 4.33 | 4.63 | 4.32 | 4.60 | 33403.00 |
| Sep 25, 2026 | 4.39 | 4.50 | 4.36 | 4.37 | 72850.00 |
| Sep 24, 2026 | 4.62 | 4.642 | 4.355 | 4.36 | 40899.00 |
| Sep 23, 2026 | 4.67 | 4.78 | 4.55 | 4.62 | 41334.00 |
| Sep 22, 2026 | 4.50 | 4.90 | 4.50 | 4.72 | 65141.00 |
| Sep 21, 2026 | 4.55 | 4.635 | 4.40 | 4.49 | 29589.00 |
| Sep 18, 2026 | 4.61 | 4.74 | 4.45 | 4.45 | 114163.0 |
| Sep 17, 2026 | 4.70 | 4.790 | 4.57 | 4.65 | 41344.00 |
| Sep 16, 2026 | 4.66 | 4.695 | 4.53 | 4.53 | 48296.00 |
| Sep 15, 2026 | 4.75 | 4.77 | 4.514 | 4.58 | 46440.00 |
| Sep 14, 2026 | 4.91 | 5.06 | 4.70 | 4.78 | 43104.00 |
| Sep 11, 2026 | 4.99 | 5.03 | 4.80 | 4.91 | 41892.00 |
| Sep 10, 2026 | 5.06 | 5.25 | 4.86 | 4.95 | 56966.00 |
| Sep 09, 2026 | 5.25 | 5.40 | 5.05 | 5.06 | 47809.00 |
| Sep 08, 2026 | 5.30 | 5.414 | 5.04 | 5.26 | 112198.0 |
| Sep 04, 2026 | 5.28 | 5.525 | 5.25 | 5.30 | 12197.00 |
| Sep 03, 2026 | 5.48 | 5.63 | 5.27 | 5.36 | 55386.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 73.62 |
| Corcept Therapeutics, Inc. | 121.16 |
| Veru, Inc. | 2.46 |
| Johnson & Johnson | 261.04 |
| Eli Lilly & Co. | 1177.72 |
Price Related Metrics
| PS Ratio | 2.298 |
| Price to Book Value | 16.79 |
| Earnings Yield | -39.74% |
| Market Cap | 72.32M |